Earnings Per Share

6 Months Ended

Jun. 30, 2020

The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2020 and 2019 (in thousands, except per share amounts):


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Earnings per Common Share - basic:
Numerator:
Net income (loss)	$	23,236	$	(22,582)	$	198,545	$	13,423
Net (income) loss attributable to noncontrolling interests in CPLP from continuing operations	(5)		265		(307)		(323)
Net income attributable to other noncontrolling interests	(130)		(92)		(194)		(168)
Net income (loss) available to common stockholders	$	23,101	$	(22,409)	$	198,044	$	12,932

Denominator:
Weighted average common shares - basic	148,548		112,926		147,986		109,049


Net income (loss) per common share - basic	$	0.16	$	(0.20)	$	1.34	$	0.12

Earnings per common share - diluted:
Numerator:
Net income (loss)	$	23,236	$	(22,582)	$	198,545	$	13,423
Net income attributable to other noncontrolling interests	(130)		(92)		(194)		(168)
Net income (loss) available for common stockholders before allocation of net income attributable to noncontrolling interests in CPLP	$	23,106	$	(22,674)	$	198,351	$	13,255

Denominator:
Weighted average common shares - basic	148,548		112,926		147,986		109,049
Add:
Potential dilutive common shares - stock options	5		—		10		29
Potential dilutive common shares - restricted stock units, less shares assumed purchased at market price	2		—		2		—
Weighted average units of CPLP convertible into common shares	25		1,744		572		1,744
Weighted average common shares - diluted	148,580		114,670		148,570		110,822


Net income (loss) per common share - diluted	$	0.16	$	(0.20)	$	1.34	$	0.12

Antidilutive restricted stock units, less share assumed purchased at market price, and antidilutive stock options outstanding	18		27		7		—

For the three and six months ended June 30, 2020, 18,000 and 7,000 restricted stock units, less shares assumed purchased at market price, respectively, were not included in the diluted weighted average common shares because they would have been antidilutive for the period presented. These restricted stock units could be dilutive in the future.

For the three months ended June 30, 2019, 27,000 stock options had an exercise price that did not exceed the average market value of the Company's stock. They were not included in the diluted weighted average common shares due to the net loss during the period. These antidilutive stock options could be dilutive in the future.